Company / Current Liabilities per Share
Twist Bioscience Corp Current Liabilities per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.53
FY2025
5-year range
$1.22 / $1.68
FY2021-FY2025
Trend
+24.9%
vs FY2024
Sector context
#85 of 212
Health Care
What the data says
At $1.53, Twist Bioscience Corp's current liabilities per share ranks #128 of 212 in the Health Care sector. Current Liabilities per Share returned to growth in FY2025 after 2 years of decline, reaching $1.53.
Based on SEC 10-K filings.
1.53 in FY2025 with a 5-year CAGR of +10.7%.
Increased from $1.29 to $1.53 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -3.2%
- 5-Year CAGR
- +10.7%
- 10-Year CAGR
- -
Sector benchmark
#128 of 212 in Health CareTop 60% of 212This company $1.53 Sector average $15.64
▼
-90.2% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 24.9% year-over-year.
- Ranks #85 out of 212 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2018.
- Lowest current liabilities per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.53 | +24.9% |
| FY2024 | $1.22 | -5.0% |
| FY2023 | $1.29 | -23.4% |
| FY2022 | $1.68 | +28.8% |
| FY2021 | $1.31 | +42.1% |
| FY2020 | $0.92 | -16.8% |
| FY2019 | $1.11 | -100.0% |
| FY2018 | $6636.95 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026